Shinshu University HOMEJAPANESEAccess / Campus Map

Shinshu University Researcher DirectoryShinshu University Researcher Directory

Search by Researcher / Research Field
Search by Category

Umemura Takeji

Academic OrganizationAcademic Assembly School of Medicine and Health Sciences Institute of MedicineTEL
Education and Research OrganizationSchool of MedicineFAX
PositionProfessorMail Address
Address3-1-1 Asahi Matsumoto Nagano 390-8621Web sitehttps://www.shinshu-u.ac.jp/faculty/medicine/chair/i-2nai/

Modified:07/29/2021

Profile

Research Field
Gastroenterology
Hepatology
Academic Societies
Academic Societies
EASL
AGA
JSH
AASLD
IDSA

Research

Books, Articles, etc.
Books
消化機能検査 肝・胆道機能検査, 臨床検査法提要改訂第35版, 1505-1511 1515-1547
金原出版 2020(May 10)
Author:梅村武司


消化機能検査 introduction, 臨床検査法提要改訂第35版, 1475
金原出版 2020(May 10)
Author:梅村武司


臓器別病変の診断と治療 肝病変 治療と予後, IgG4関連疾患 改定第2版, 130
株式会社診断と治療社 2019(Dec. 06)
Author:梅村武司


臓器別病変の診断と治療 肝病変 検査・診断, IgG4関連疾患 改定第2版, 128-129
株式会社診断と治療社 2019(Dec. 06)
Author:梅村武司


臓器別病変の診断と治療 肝病変 病態, IgG4関連疾患 改定第2版, 126-127
株式会社診断と治療社 2019(Dec. 06)
Author:梅村武司


長野県における肝硬変の成因実態, 肝硬変の成因別実態, 80-81
医学図書出版 2019(Mar. 15)
Author:杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司


C型肝炎ウイルスの減菌・消毒, ナースのための肝炎看護ハンドブック改訂版, 72-80
医療ジャーナル社 2016(Sep. 20)
Author:梅村武司


針刺し事故の予防および対策, ナースのための肝炎看護ハンドブック改訂版, 61-71
医療ジャーナル社 2016(Sep. 20)
Author:梅村武司


腎機能障害症例、透析症例, 最新・C型肝炎経口薬治療マニュアル, 60-61
診断と治療社 2016(Apr. 01)
Author:梅村武司


ウイルス性肝炎や肝障害を認めたらどう対処すべきか?, リウマチ・膠原病診療ハイグレード リウマチ・膠原病の合併症や諸問題を解く, 274-283
文光堂 2016(Jan. 21)
Author:梅村武司


Articles
Relationship of early acute complications and insertion site in push method percutaneous endoscopic gastrostomy
Sci Rep,10(1):20551 2020(Nov. 25)
Author:Suzuki H, Joshita S, Nagaya T, Sato K, Ito A, Suga T, Umemura T


Editorial: FAST score- a new predictive marker for HCC after SVR
Aliment Pharmacol Ther,52(7):1222-1223 2020(Oct. 01)
Author:Joshita S, Umemura T


Invasive liver abscess syndrome accompanied by spondylodiscitis: a case report and review of the literature
Clin J Gastroenterol,13(5):927-934 2020(Oct. 01)
Author:Wakabayashi SI, Kimura T, Tanaka N, Pham J, Tanaka T, Higuchi S, Kobayashi J, Umemura T, Iijima A


A case report of pancreatic panniculitis due to acute pancreatitis with intraductal papillary mucinous neoplasm
BMC Gastroenterol,20(1):286 2020(Aug. 24)
Author:Yamashita Y, Joshita S, Ito T, Maruyama M, Wada S, Umemura T


減量導入したレゴラフェニブが奏功し、12ヵ月以上の長期投与が可能であった多発肝細胞癌・胸椎および副腎転移の1例
肝臓,61(8):426-433 2020(Aug. 01)
Author:岩垂隆諒, 山崎智生, 城下智, 藤森尚之, 金井圭太, 山下裕騎, 高橋芳之, 杉浦亜弓, 梅村武司


Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection
JGH Open,4(4):574-581 2020(Aug. 01)
Author:Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E:


Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese
Sci Rep,10(1):12424 2020(Jul. 24)
Author:Suzuki H, Joshita S, Hirayama A, Shinji A, Mukawa K, Sako M, Yoshimura N, Suga T, Umemura T, Ashihara N, Yamazaki T, Ota M


【IgG4関連疾患-診断と治療の最新動向】IgG4関連消化器疾患の診断と治療
カレントテラピー,38(7):669-675 2020(Jul. 01)
Author:渡邉貴之, 梅村武司, 川茂幸


Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
J Gastroenterol Hepatol,35(7):1208-1214 2020(Jul. 01)
Author:Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T


Correlation of Pancreatic T1 Values Using Modified Look-Locker Inversion Recovery Sequence (MOLLI) with Pancreatic Exocrine and Endocrine Function
J Clin Med,9(6) 2020(Jun. 10)
Author:Ashihara N, Watanabe T, Kako S, Kuraishi Y, Ozawa M, Shigefuji S, Kanai K, Usami Y, Yamada A, Umemura T, Fujinaga Y


B型肝炎再活性化発症に関連するウイルス側因子
肝臓,61(5):237-239 2020(May 01)
Author:伊藤 清顕;梅村 武司;坂本 和賢;奥村 彰規;田中 榮司;米田 政志


Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease
Clin J Gastroenterol,13(3):434-442 2020(Apr. 03)
Author:Kurihara S, Kimura T, Tanaka N, Yanagisawa T, Kobayashi H, Kanai K, Umemura T, Kobayashi M, Mori H, Wada S


Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
Biomedicines,8(4) 2020(Apr. 03)
Author:Sugiura A, Joshita S, Yamashita Y, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Nakano Y, Usuda S, Kiyosawa K, Tanaka E, Umemura T


【消化器領域におけるIgG4関連疾患】IgG4関連自己免疫性肝炎
消化器内科,2(4):83-91 2020(Apr. 01)
Author:梅村武司


【ウイルス肝炎アップデート】B型・C型肝炎の治療と予防 B型肝炎ウイルスの再活性化
診断と治療,108(2):215-220 2020(Feb. 01)
Author:梅村武司


Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Clin J Gastroenterol,13(1):83-89 2020(Feb. 01)
Author:Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E


Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
JOURNAL OF INFECTIOUS DISEASES,221(3):400-407 2020(Jan. 14)
Author:Sakamoto, Kazumasa; Umemura, Takeji; Ito, Kiyoaki; Okumura, Akinori; Joshita, Satoru; Ota, Masao; Sugiyama, Masaya; Mizokami, Masashi; Yoneda, Masashi; Tanaka, Eiji;


Clinical In uence of Hepatitis C Virus Eradication by Direct-acting Antivirals on Lipid Levels and “Ningen Dock” Health Check-up Categories in Patients with Chronic Hepatitis C Virus Infection
Ningen Dock International,7:19-25 2020( 01)
Author:Joshita S, Sugiura A, Yamazaki T, Fujimori N, Yamashita Y, Matsumoto A, Eiji T, Takeji U


Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
HEPATOLOGY,70(6):2035-2046 2019(Dec.)
Author:Honda, Akira; Tanaka, Atsushi; Kaneko, Tetsuji; Komori, Atsumasa; Abe, Masanori; Inao, Mie; Namisaki, Tadashi; Hashimoto, Naoaki; Kawata, Kazuhito; Takahashi, Atsushi; Ninomiya, Masashi; Kang, Jong-Hon; Arakawa, Mie; Yamagiwa, Satoshi; Joshita, Satoru; Umemura, Takeji; Sato, Ken; Kaneko, Akira; Kikuchi, Kentaro; Itakura, Jun; Nomura, Takako; Kakisaka, Keisuke; Fujii, Hideki; Kawada, Norifumi; Takikawa, Yasuhiro; Masaki, Tsutomu; Ohira, Hiromasa; Mochida, Satoshi; Yoshiji, Hitoshi; Iimuro, Satoshi; Matsuzaki, Yasushi; Takikawa, Hajime; Japan PBC Study Grp;


Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
HEPATOLOGY RESEARCH,49(10):1236-1243 2019(Oct.)
Author:Joshita, Satoru; Umemura, Takeji; Yamashita, Yuki; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Tanaka, Eiji;


CLINICAL SIGNIFICANCE OF TUMOR MARKERS IN SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A MULTICENTER PROSPECTIVE COHORT STUDY IN JAPAN
HEPATOLOGY,70:225A-226A 2019(Oct.)
Author:Uchino, Koji; Tateishi, Ryosuke; Fujiwara, Naoto; Mitsuhiko, Moriyama; Eguchi, Yuichiro; Toyoda, Hidenori; Ida, Yoshiyuki; Karino, Yoshiyasu; Kudo, Masatoshi; Chuma, Makoto; Takuma, Yoshitaka; Kaneko, Shuichi; Kato, Naoya; Chayama, Kazuaki; Izumi, Namiki; Itoi, Takao; Sakaida, Isao; Komeda, Hideyuki; Umemura, Takeji; Ishikawa, Toru; Nakamuta, Makoto; Takaki, Akinobu; Terai, Shuji; Ido, Akio; Enomoto, Nobuyuki; Yoshida, Hitoshi; Baba, Toshiyuki; Torimura, Takuji; Hiasa, Yoichi; Ogawa, Chikara; Takehara, Tetsuo; Kumada, Takashi; Koike, Kazuhiko;


MULTI-CENTER AND PROSPECTIVE COHORT STUDY OF 599 JAPANESE PATIENTS WITH HCV GENOTYPE 1 INFECTION REVEALS SUSTAINED VIROLOGICAL RESPONSE BY LEDIPASVIR/SOFOSBUVIR REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA AS SAME AS PEG-INTERFERON PLUS RIBAVIRIN
HEPATOLOGY,70:368A-369A 2019(Oct.)
Author:Korenaga, Masaaki; Izumi, Namiki; Tamaki, Nobuharu; Yokosuka, Osamu; Kanda, Tatsuo; Takehara, Tetsuo; Sakamoto, Naoya; Suda, Goki; Nishiguchi, Shuhei; Enomoto, Hirayuiki; Ikeda, Fusao; Yanase, Mikio; Toyoda, Hidenori; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Yamasaki, Kazumi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Haga, Hiroaki; Nishigaki, Yohichi; Nakane, Kunio; Omata, Masao; Mochiduki, Hitoshi; Kanto, Tatsuya; Mizokami, Masashi;


KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTORS/HUMAN LEUKOCYTE ANTIGEN GENOTYPES CONFER SUSCEPTIBILITY AND PROGRESSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS
HEPATOLOGY,70:871A-871A 2019(Oct.)
Author:Umemura, Takeji; Joshita, Satoru; Yamashita, Yuki; Yoshizawa, Kaname; Norman, Gary L.; Tanaka, Eiji; Ota, Masao;


Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
MEDICINE,98(30):- 2019(Jul.)
Author:Kobayashi, Satoshi; Joshita, Satoru; Yamamoto, Chikara; Yanagisawa, Takumi; Miyazawa, Takayuki; Miyazawa, Megumi; Kubota, Daisuke; Sato, Junichi; Umemura, Takeji; Tanaka, Eiji;


Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
MEDICINE,98(6):- 2019(Feb.)
Author:Umemura, Takeji; Joshita, Satoru; Shibata, Soichiro; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Tanaka, Eiji;


Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,:- 2019
Author:Joshita, Satoru; Yamashita, Yuki; Sugiura, Ayumi; Uehara, Takeshi; Usami, Yoko; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Tanaka, Eiji; Umemura, Takeji;


POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33
SCIENTIFIC REPORTS,9:- 2019
Author:Hitomi, Yuki; Ueno, Kazuko; Kawai, Yosuke; Nishida, Nao; Kojima, Kaname; Kawashima, Minae; Aiba, Yoshihiro; Nakamura, Hitomi; Kouno, Hiroshi; Kouno, Hirotaka; Ohta, Hajime; Sugi, Kazuhiro; Nikami, Toshiki; Yamashita, Tsutomu; Katsushima, Shinji; Komeda, Toshiki; Ario, Keisuke; Naganuma, Atsushi; Shimada, Masaaki; Hirashima, Noboru; Yoshizawa, Kaname; Makita, Fujio; Furuta, Kiyoshi; Kikuchi, Masahiro; Naeshiro, Noriaki; Takahashi, Hironao; Mano, Yutaka; Yamashita, Haruhiro; Matsushita, Kouki; Tsunematsu, Seiji; Yabuuchi, Iwao; Nishimura, Hideo; Shimada, Yusuke; Yamauchi, Kazuhiko; Komatsu, Tatsuji; Sugimoto, Rie; Sakai, Hironori; Mita, Eiji; Koda, Masaharu; Nakamura, Yoko; Kamitsukasa, Hiroshi; Sato, Takeaki; Nakamuta, Makoto; Masaki, Naohiko; Takikawe, Hajime; Tanaka, Atsushi; Ohira, Hiromasa; Zeniya, Mikio; Abe, Masanori; Kaneko, Shuichi; Honda, Masao; Arai, Kuniaki; Arinaga-Hino, Teruko; Hashimoto, Etsuko; Taniai, Makiko; Umemura, Takeji; Joshita, Satoru; Nakao, Kazuhiko; Ichikawa, Tatsuki; Shibata, Hidetaka; Takaki, Akinobu; Yamagiwa, Satoshi; Seike, Masataka; Sakisaka, Shotaro; Takeyama, Yasuaki; Harada, Masaru; Senju, Michio; Yokosuka, Osamu; Kanda, Tatsuo; Ueno, Yoshiyuki; Ebinuma, Hirotoshi; Himoto, Takashi; Murata, Kazumoto; Shimoda, Shinji; Nagaoka, Shinya; Abiru, Seigo; Komori, Atsumasa; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Maehara, Yoshihiko; Uemoto, Shinji; Kokudo, Norihiro; Nagasaki, Masao; Tokunaga, Katsushi; Nakamura, Minoru;


Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
HEPATOLOGY RESEARCH,48(13):1092-1098 2018(Dec.)
Author:Komatsu, Michiharu; Tanaka, Naoki; Kimura, Takefumi; Fujimori, Naoyuki; Sano, Kenji; Horiuchi, Akira; Sugiura, Ayumi; Yamazaki, Tomoo; Shibata, Soichiro; Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;


Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
JOURNAL OF VIRAL HEPATITIS,25(12):1462-1471 2018(Dec.)
Author:Sugiura, Ayumi; Joshita, Satoru; Umemura, Takeji; Yamazaki, Tomoo; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Usami, Yoko; Wada, Shuichi; Mori, Hiromitsu; Shibata, Soichiro; Yoshizawa, Kaname; Morita, Susumu; Furuta, Kiyoshi; Kamijo, Atsushi; Iijima, Akihiro; Kako, Satoko; Maruyama, Atsushi; Kobayashi, Masakazu; Komatsu, Michiharu; Matsumura, Makiko; Miyabayashi, Chiharu; Ichijo, Tetsuya; Takeuchi, Aki; Koike, Yuriko; Gibo, Yukio; Tsukadaira, Toshihisa; Inada, Hiroyuki; Kiyosawa, Kendo; Tanaka, Eiji;


Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
CYTOKINE,111:357-363 2018(Nov.)
Author:Umemura, Takeji; Yamazaki, Tomoo; Joshita, Satoru; Sugiura, Ayumi; Fujimori, Naoyuki; Matsumoto, Akihiro; Ota, Masao; Tanaka, Eiji;


Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey
JOURNAL OF GASTROENTEROLOGY,53(9):1079-1088 2018(Sep.)
Author:Joshita, Satoru; Yoshizawa, Kaname; Umemura, Takeji; Ohira, Hiromasa; Takahashi, Atsushi; Harada, Kenichi; Nguyen Canh Hiep; Tsuneyama, Koichi; Kage, Masayoshi; Nakano, Masayuki; Kang, Jong-Hon; Koike, Kazuhiko; Zeniya, Mikio; Yasunaka, Tetsuya; Takaki, Akinobu; Torimura, Takuji; Abe, Masanori; Yokosuka, Osamu; Tanaka, Atsushi; Takikawa, Hajime; Japan Autoimmune Hepatitis Study G;


A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
JOURNAL OF INFECTION AND CHEMOTHERAPY,24(5):393-397 2018(May)
Author:Yamazaki, Tomoo; Joshita, Satoru; Kasuga, Eriko; Horiuchi, Kazuki; Sugiura, Ayumi; Fujimori, Naoyuki; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;


Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
HEPATOLOGY RESEARCH,48(4):275-285 2018(Mar.)
Author:Joshita, Satoru; Ichikawa, Yuki; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Shibata, Soichiro; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji;


長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の2例
信州医学雑誌,66(1):39-49 2018(Feb. 10)
Author:杉浦 亜弓,城下 智,山下 裕騎,木村 岳史,山崎 智生,藤森 尚之,小松 通治,松本 晶博,小林 翔太,梅村 武司,田中 榮司


B型肝炎再活性化の対策 (特集 肝炎ウイルス克服時代の肝臓病学)
日本内科学会雑誌,107(1):26-31 2018(Jan. 10)
Author:梅村 武司;


長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の2例
信州医学雑誌,66(1):39-49 2018
Author:杉浦 亜弓;梅村 武司;田中 榮司;城下 智;山下 裕騎;木村 岳史;山崎 智生;藤森 尚之;小松 通治;松本 晶博;小林 翔太


III.B型肝炎再活性化の対策
日本内科学会雑誌,107(1):26-31 2018
Author:梅村 武司


Direct Acting Antiviral(DAA)の登場で変化を遂げたC型肝炎治療
信州医学雑誌,66(6):475-477 2018
Author:杉浦 亜弓;城下 智;梅村 武司


A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
SCIENTIFIC REPORTS,8:- 2018
Author:Yamazaki, Tomoo; Umemura, Takeji; Joshita, Satoru; Yoshizawa, Kaname; Tanaka, Eiji; Ota, Masao;


多発肝細胞癌・腸骨転移に対し放射線照射・肝動脈化学塞栓術・sorafenib内服を組み合わせた集学的治療を行い長期寛解が得られた1例
肝臓,59(2):117-124 2018
Author:若林 俊一; 山崎 智生; 城下 智; 黒住 昌弘; 杉浦 亜弓; 藤森 尚之; 柴田 壮一郎; 市川 雪; 森田 進; 小松 通治; 梅村 武司; 松本 晶博; 田中 榮司;


ビタミンB6が著効したALAS2 R452H変異陽性X連鎖性鉄芽球性貧血
臨床血液,59(4):401-406 2018
Author:川上 徹; 中澤 英之; 川上 史裕; 松澤 周治; 須藤 裕里子; 酒井 均; 仁科 さやか; 妹尾 紀子; 妹尾 寧; 小松 通治; 梅村 武司; 山口 智美; 古庄 知己; 藤原 亨; 張替 秀郎; 石田 文宏;


Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
WORLD JOURNAL OF GASTROENTEROLOGY,24(11):1239-1249 2018
Author:Fujimori, Naoyuki; Umemura, Takeji; Kimura, Takefumi; Tanaka, Naoki; Sugiura, Ayumi; Yamazaki, Tomoo; Joshita, Satoru; Komatsu, Michiharu; Usami, Yoko; Sano, Kenji; Igarashi, Koji; Matsumoto, Akihiro; Tanaka, Eiji;


Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
PLOS ONE,13(4):- 2018
Author:Yamazaki, Tomoo; Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji;


Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
WORLD JOURNAL OF GASTROENTEROLOGY,24(13):1440-1450 2018
Author:Kimura, Takefumi; Tanaka, Naoki; Fujimori, Naoyuki; Sugiura, Ayumi; Yamazaki, Tomoo; Joshita, Satoru; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;


Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population
PLOS ONE,13(4):- 2018
Author:Saito, Hiromi; Hirayama, Atsuhiro; Umemura, Takeji; Joshita, Satoru; Mukawa, Kenji; Suga, Tomoaki; Tanaka, Eiji; Ota, Masao;


Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
SCIENTIFIC REPORTS,8:- 2018
Author:Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Yamashita, Yuki; Norman, Gary L.; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji;


Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
JOURNAL OF HUMAN GENETICS,62(11):963-967 2017(Nov.)
Author:Umemura, Takeji; Joshita, Satoru; Hamano, Hideaki; Yoshizawa, Kaname; Kawa, Shigeyuki; Tanaka, Eiji; Ota, Masao;


Association between lower air pressure and the onset of ischemic colitis: a case-control study
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,29(9):1071-1078 2017(Sep.)
Author:Kimura, Takefumi; Shinji, Akihiro; Tanaka, Naoki; Koinuma, Masayoshi; Yamaura, Maki; Nagaya, Tadanobu; Joshita, Satoru; Komatsu, Michiharu; Umemura, Takeji; Horiuchi, Akira; Wada, Shuichi; Tanaka, Eiji;


Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
LIVER INTERNATIONAL,37(6):897-905 2017(Jun.)
Author:Umemura, Takeji; Sekiguchi, Tomohiro; Joshita, Satoru; Yamazaki, Tomoo; Shibata, Soichiro; Ichikawa, Yuki; Komatsu, Michiharu; Matsumoto, Akihiro; Shums, Zakera; Norman, Gary L.; Tanaka, Eiji; Ota, Masao;


インターフェロン,核酸アナログ製剤の選択 : 適応と治療の実際 (特集 B型・C型肝炎の最新治療戦略 : どの治療を選択すべきか) -- (B型肝炎)
消化器の臨床,20(1):20-23 2017(Feb.)
Author:梅村 武司;


Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
HEPATOLOGY RESEARCH,47(2):226-233 2017(Feb.)
Author:Ichikawa, Yuki; Joshita, Satoru; Umemura, Takeji; Shobugawa, Yugo; Usami, Yoko; Shibata, Soichiro; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji;


Immunogenetics of IgG4-Related AIP
IGG4-RELATED DISEASE,401:35-44 2017
Author:Ota, Masao; Umemura, Takeji; Kawa, Shigeyuki;


Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
HUMAN MOLECULAR GENETICS,26(3):650-659 2017
Author:Kawashima, Minae; Hitomi, Yuki; Aiba, Yoshihiro; Nishida, Nao; Kojima, Kaname; Kawai, Yosuke; Nakamura, Hitomi; Tanaka, Atsushi; Zeniya, Mikio; Hashimoto, Etsuko; Ohira, Hiromasa; Yamamoto, Kazuhide; Abe, Masanori; Nakao, Kazuhiko; Yamagiwa, Satoshi; Kaneko, Shuichi; Honda, Masao; Umemura, Takeji; Ichida, Takafumi; Seike, Masataka; Sakisaka, Shotaro; Harada, Masaru; Yokosuka, Osamu; Ueno, Yoshiyuki; Senju, Michio; Kanda, Tatsuo; Shibata, Hidetaka; Himoto, Takashi; Murata, Kazumoto; Miyake, Yasuhiro; Ebinuma, Hirotoshi; Taniai, Makiko; Joshita, Satoru; Nikami, Toshiki; Ota, Hajime; Kouno, Hiroshi; Kouno, Hirotaka; Nakamuta, Makoto; Fukushima, Nobuyoshi; Kohjima, Motoyuki; Komatsu, Tatsuji; Komeda, Toshiki; Ohara, Yukio; Muro, Toyokichi; Yamashita, Tsutomu; Yoshizawa, Kaname; Nakamura, Yoko; Shimada, Masaaki; Hirashima, Noboru; Sugi, Kazuhiro; Ario, Keisuke; Takesaki, Eiichi; Naganuma, Atsushi; Mano, Hiroshi; Yamashita, Haruhiro; Matsushita, Kouki; Yamauchi, Kazuhiko; Makita, Fujio; Nishimura, Hideo; Furuta, Kiyoshi; Takahashi, Naohiro; Kikuchi, Masahiro; Masaki, Naohiko; Tanaka, Tomohiro; Tamura, Sumito; Mori, Akira; Yagi, Shintaro; Shirabe, Ken; Komori, Atsumasa; Migita, Kiyoshi; Ito, Masahiro; Nagaoka, Shinya; Abiru, Seigo; Yatsuhashi, Hiroshi; Yasunami, Michio; Shimoda, Shinji; Harada, Kenichi; Egawa, Hiroto; Maehara, Yoshihiko; Uemoto, Shinji; Kokudo, Norihiro; Takikawa, Hajime; Ishibashi, Hiromi; Chayama, Kazuaki; Mizokami, Masashi; Nagasaki, Masao; Tokunaga, Katsushi; Nakamura, Minoru;


Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
JOURNAL OF IMMUNOLOGY RESEARCH,:- 2017
Author:Joshita, Satoru; Umemura, Takeji; Tanaka, Eiji; Ota, Masao;


Association between endotoxemia and histological features of nonalcoholic fatty liver disease
WORLD JOURNAL OF GASTROENTEROLOGY,23(4):712-722 2017
Author:Kitabatake, Hiroyuki; Tanaka, Naoki; Fujimori, Naoyuki; Komatsu, Michiharu; Okubo, Ayaka; Kakegawa, Kyogo; Kimura, Takefumi; Sugiura, Ayumi; Yamazaki, Tomoo; Shibata, Soichiro; Ichikawa, Yuki; Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Koinuma, Masayoshi; Sano, Kenji; Aoyama, Toshifumi; Tanaka, Eiji;


Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis
HEPATOLOGY RESEARCH,46(10):1019-1027 2016(Sep.)
Author:Fujimori, Naoyuki; Tanaka, Naoki; Shibata, Soichiro; Sano, Kenji; Yamazaki, Tomoo; Sekiguchi, Tomohiro; Kitabatake, Hiroyuki; Ichikawa, Yuki; Kimura, Takefumi; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji;


Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C
HEPATOLOGY RESEARCH,46(9):884-889 2016(Aug.)
Author:Shibata, Soichiro; Umemura, Takeji; Yamazaki, Tomoo; Fujimori, Naoyuki; Ichikawa, Yuki; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji;


Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan
HEPATOLOGY RESEARCH,46(9):878-883 2016(Aug.)
Author:Yoshizawa, Kaname; Joshita, Satoru; Matsumoto, Akihiro; Umemura, Takeji; Tanaka, Eiji; Morita, Susumu; Maejima, Toshitaka; Ota, Masao;


Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease
SEMINARS IN LIVER DISEASE,36(3):229-241 2016(Aug.)
Author:Nakanuma, Yasuni; Ishizu, Yoji; Zen, Yoh; Harada, Kenichi; Umemura, Takeji;


Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C
HEPATOLOGY,63(6):2063-2064 2016(Jun.)
Author:Shibata, Soichiro; Umemura, Takeji; Komatsu, Michiharu; Tanaka, Eiji;


A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
信州医学雑誌,64(2):75-78 2016(Apr. 10)
Author:Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji


Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,31(1):180-189 2016(Jan.)
Author:Ito, Kiyoaki; Yotsuyanagi, Hiroshi; Sugiyama, Masaya; Yatsuhashi, Hiroshi; Karino, Yoshiyasu; Takikawa, Yasuhiro; Saito, Takafumi; Arase, Yasuji; Imazeki, Fumio; Kurosaki, Masayuki; Umemura, Takeji; Ichida, Takafumi; Toyoda, Hidenori; Yoneda, Masashi; Tanaka, Yasuhito; Mita, Eiji; Yamamoto, Kazuhide; Michitaka, Kojiro; Maeshiro, Tatsuji; Tanuma, Junko; Korenaga, Masaaki; Murata, Kazumoto; Masaki, Naohiko; Koike, Kazuhiko; Mizokami, Masashi; Japanese AHB CHB Study Grp;


Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease
SPRINGERPLUS,5:- 2016
Author:Shibata, Soichiro; Joshita, Satoru; Umemura, Takeji; Yamazaki, Tomoo; Fujimori, Naoyuki; Ichikawa, Yuki; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji;


Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan
SCIENTIFIC REPORTS,6:- 2016
Author:Umemura, Takeji; Joshita, Satoru; Yamazaki, Tomoo; Komatsu, Michiharu; Katsuyama, Yoshihiko; Yoshizawa, Kaname; Tanaka, Eiji; Ota, Masao;


Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis
Clinical Journal of Gastroenterology,8(6):360-366 2015(Dec. 10)
Author:Umemura, Takeji; Ota, Masao


Treatment with the single-tablet regimen ledipasvir/sofosbuvir for 12weeks results in 100% sustained virologic response in Japanese patients with chronic genotype-1 hepatitis C virus infection
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,30:372-373 2015(Dec.)
Author:Mizokami, Masashi; Takehara, Tetsuo; Yokosuka, Osamu; Sakamoto, Naoya; Korenaga, Masaaki; Mochizuki, Hitoshi; Nakane, Kunio; Enomoto, Hirayuki; Yanase, Mikio; Toyoda, Hidenori; Ikeda, Fusao; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Nishigaki, Yoichi; Betular, Juan; Gao, Bing; Ishizaki, Akinobu; Omote, Masa; Liu, Vivian; Pang, Phillip S.; Knox, Steven J.; Symonds, William T.; Mchutchison, John G.; Izumi, Namiki; Omata, Masao;


Factors associated with the effect of interferon-alpha sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B
HEPATOLOGY RESEARCH,45(12):1195-1202 2015(Dec.)
Author:Matsumoto, Akihiro; Yatsuhashi, Hiroshi; Nagaoka, Shinya; Suzuki, Yoshiyuki; Hosaka, Tetsuya; Tsuge, Masataka; Chayama, Kazuaki; Kanda, Tatsuo; Yokosuka, Osamu; Nishiguchi, Shuhei; Saito, Masaki; Miyase, Shiho; Kang, Jong-Hon; Shinkai, Noboru; Tanaka, Yasuhito; Umemura, Takeji; Tanaka, Eiji;


Primary hepatocellular carcinoma in a patient with neurofibromatosis type I
LIVER INTERNATIONAL,35(8):2057-2058 2015(Aug.)
Author:Kimura, Takefumi; Tanaka, Naoki; Umemura, Takeji; Tanaka, Eiji;


Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis
HEPATOLOGY RESEARCH,45(7):739-744 2015(Jul.)
Author:Umemura, Takeji; Shibata, Soichiro; Sekiguchi, Tomohiro; Kitabatake, Hiroyuki; Nozawa, Yuichi; Okuhara, Sadahisa; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji;


Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis
AMERICAN JOURNAL OF GASTROENTEROLOGY,110(6):857-864 2015(Jun.)
Author:Umemura, Takeji; Joshita, Satoru; Sekiguchi, Tomohiro; Usami, Yoko; Shibata, Soichiro; Kimura, Takefumi; Komatsu, Michiharu; Matsumoto, Akihiro; Ota, Masao; Tanaka, Eiji;


Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPAR alpha
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,1852(3):473-481 2015(Mar.)
Author:Komatsu, Michiharu; Kimura, Takefumi; Yazaki, Masahide; Tanaka, Naoki; Yang, Yang; Nakajima, Takero; Horiuchi, Akira; Fang, Zhong-Ze; Joshita, Satoru; Matsumoto, Akihiro; Umemura, Takeji; Tanaka, Eiji; Gonzalez, Frank J.; Ikeda, Shu-Ichi; Aoyama, Toshifumi;


国内におけるde novo B型肝炎の実態と肝臓学会によるB型肝炎治療ガイドライン
血液内科,70(1):123-127 2015(Jan.)
Author:梅村 武司;


Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
PLOS ONE,10(6):- 2015
Author:Sekiguchi, Tomohiro; Umemura, Takeji; Fujimori, Naoyuki; Shibata, Soichiro; Ichikawa, Yuki; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao;


Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion
WORLD JOURNAL OF GASTROENTEROLOGY,21(2):541-548 2015
Author:Kamijo, Nozomi; Matsumoto, Akihiro; Umemura, Takeji; Shibata, Soichiro; Ichikawa, Yuki; Kimura, Takefumi; Komatsu, Michiharu; Tanaka, Eiji;


Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
CLINICA CHIMICA ACTA,441:176-181 2015
Author:Pavlidis, Polychronis; Shums, Zakera; Koutsoumpas, Andreas L.; Milo, Jay; Papp, Maria; Umemura, Takeji; Lakatos, Peter L.; Smyk, Daniel S.; Bogdanos, Dimitrios P.; Forbes, Alastair; Norman, Gary L.;


C型肝炎の新規治療法
信州医学雑誌,63(6):367-374 2015
Author:梅村 武司;


Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis
HEPATOLOGY RESEARCH,44(13):1299-1307 2014(Dec.)
Author:Miyake, Yasuhiro; Yamamoto, Kazuhide; Matsushita, Hiroshi; Abe, Masanori; Takahashi, Atsushi; Umemura, Takeji; Tanaka, Atsushi; Nakamuta, Makoto; Nakamoto, Yasunari; Ueno, Yoshiyuki; Saibara, Toshiji; Takikawa, Hajime; Yoshizawa, Kaname; Ohira, Hiromasa; Zeniya, Mikio; Onji, Morikazu; Tsubouchi, Hirohito; Intractable Hepato-Biliary Dis;


AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis
JOURNAL OF HEPATOLOGY,61(6):1443-1445 2014(Dec.)
Author:Joshita, Satoru; Umemura, Takeji; Ota, Masao; Tanaka, Eiji;


Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
Hepatol Res,44(10):E172-80 2014(Oct.)
Author:Okuhara S, Umemura T, Joshita S, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E


Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B
Hepatol Res,44(10):E45-53 2014(Oct.)
Author:Morita S, Matsumoto A, Umemura T, Shibata S, Kamijo N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Yoshizawa K, Tanaka E


KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C
HUMAN IMMUNOLOGY,75(8):822-826 2014(Aug.)
Author:Umemura, Takeji; Ota, Masao; Katsuyama, Yoshihiko; Wada, Shuichi; Mori, Hiromitsu; Maruyama, Atsushi; Shibata, Soichiro; Nozawa, Yuichi; Kimura, Takefumi; Morita, Susumu; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Kamijo, Atsushi; Kobayashi, Masakazu; Takamatsu, Masato; Yoshizawa, Kaname; Kiyosawa, Kendo; Tanaka, Eiji


Laparoscopic findings of congenital hepatic fibrosis: A case report and review of the published work
HEPATOLOGY RESEARCH,44(7):818-824 2014(Jul.)
Author:Komatsu, Michiharu; Tanaka, Naoki; Shibata, So-Ichirou; Kimura, Takefumi; Ichikawa, Yuki; Morita, Susumu; Joshita, Satoru; Nagaya, Tadanobu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Tanaka, Eiji


HLA CLASS II HAPLOTYPES AFFECT CLINICAL CHARACTERISTICS AND PROGRESSION OF TYPE 1 AUTOIMMUNE HEPATITIS IN JAPAN
TISSUE ANTIGENS,84(1):153-153 2014(Jul.)
Author:Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Inoko, Hidetoshi; Ota, Masao


Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
PLOS ONE,9(6) 2014(Jun. 23)
Author:Umemura, Takeji; Katsuyama, Yoshihiko; Yoshizawa, Kaname; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao


Genetic polymorphism in IFNL4 and response to pegylated interferon-alpha and ribavirin in Japanese chronic hepatitis C patients
Tissue Antigens,83(1):45-8 2014(Jan.)
Author:Nozawa Y, Umemura T, Katsuyama Y, Shibata S, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A, Yoshizawa K, Ota M, Tanaka E


Risk Factors for Long-Term Persistence of Serum Hepatitis B Surface Antigen Following Acute Hepatitis B Virus Infection in Japanese Adults
HEPATOLOGY,59(1):89-97 2014(Jan.)
Author:Ito, Kiyoaki; Yotsuyanagi, Hiroshi; Yatsuhashi, Hiroshi; Karino, Yoshiyasu; Takikawa, Yasuhiro; Saito, Takafumi; Arase, Yasuji; Imazeki, Fumio; Kurosaki, Masayuki; Umemura, Takeji; Ichida, Takafumi; Toyoda, Hidenori; Yoneda, Masashi; Mita, Eiji; Yamamoto, Kazuhide; Michitaka, Kojiro; Maeshiro, Tatsuji; Tanuma, Junko; Tanaka, Yasuhito; Sugiyama, Masaya; Murata, Kazumoto; Masaki, Naohiko; Mizokami, Masashi; Japanese AHB Study Grp


共通生薬成分を含む漢方薬の再投与により薬物性肝障害再発をきたした1例
肝臓,55(4):214-220 2014
Author:丸山 康弘,吉澤 要,鶴田 史,丸山 雅史,藤森 一也,滋野 俊,福島 万奈,上原 剛,森田 進,城下 智,梅村 武司,田中 榮司


STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
DISEASE MARKERS 2014
Author:Joshita, Satoru; Umemura, Takeji; Nakamura, Minoru; Katsuyama, Yoshihiko; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Yoshizawa, Kaname; Ishibashi, Hiromi; Tanaka, Eiji; Ota, Masao


STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
DISEASE MARKERS,2014:727393 2014
Author:Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M


KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan
PLOS ONE,8(12) 2013(Dec. 12)
Author:Nozawa, Yuichi; Umemura, Takeji; Joshita, Satoru; Katsuyama, Yoshihiko; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao


de novo B型肝炎のウイルス学的特徴 (特集 B型肝炎ウイルス再活性化の現状と対策)
消化器内科,57(5):624-626 2013(Nov.)
Author:梅村 武司


Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
HEPATOLOGY RESEARCH,43(7):801-807 2013(Jul.)
Author:Joshita, Satoru; Shirahata, Kumiko; Yazaki, Yoshikazu; Okaniwa, Shinji; Nakamura, Yoshiyuki; Kimura, Takefumi; Noami, Sugiko; Horigome, Reiko; Yagi, Hikaru; Ito, Nobuo; Yamazaki, Asami; Akahane, Yuki; Umemura, Takeji; Yoshizawa, Kaname; Tanaka, Eiji; Ota, Masao


乳び腹水に対してオクトレオチド投与が有効であった子宮頸癌, 肝細胞癌合併C型肝硬変の1例
肝臓,54(4):284-290 2013(Apr. 25)
Author:齊藤 博美,城下 智,吉澤 要,藤森 芳史,丸山 康弘,伊藤 哲也,児玉 亮,横沢 秀一,小松 通治,梅村 武司,田中 榮司


本邦におけるde novo B型肝炎症例の背景と予後 (特集 B型肝炎再活性化の現状と対策 : 肝臓,血液,リウマチ,腫瘍領域の現状を踏まえて)
最新医学,68(3):351-354 2013(Mar.)
Author:梅村 武司


Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
HUMAN IMMUNOLOGY,74(2):219-222 2013(Feb.)
Author:Morita, Susumu; Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Kimura, Takefumi; Komatsu, Michiharu; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Astushi; Yamamura, Nobuyoshi; Tanaka, Eiji; Ota, Masao


Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
INTERNAL MEDICINE,52(17):1903-1908 2013
Author:Sekiguchi, Nodoka; Joshita, Satoru; Yoshida, Toshikazu; Kurozumi, Masahiro; Sano, Kenji; Nakagawa, Michitaka; Ito, Tetsuya; Matsushita, Tsuyoshi; Komatsu, Daisuke; Komatsu, Michiharu; Ito, Toshiro; Umemura, Takeji; Ikeda, Shu-ichi; Kadoya, Masumi; Ishida, Fumihiro; Tanaka, Eiji


Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
AMERICAN JOURNAL OF HUMAN GENETICS,91(4):721-728 2012(Oct. 05)
Author:Nakamura, Minoru; Nishida, Nao; Kawashima, Minae; Aiba, Yoshihiro; Tanaka, Atsushi; Yasunami, Michio; Nakamura, Hitomi; Komori, Atsumasai; Nakamuta, Makoto; Zeniya, Mikio; Hashimoto, Etsuko; Ohira, Hiromasa; Yamamoto, Kazuhide; Onji, Morikazu; Kaneko, Shuichi; Honda, Masao; Yamagiwa, Satoshi; Nakao, Kazuhiko; Ichida, Takafumi; Takikawa, Hajime; Seike, Masataka; Umemura, Takeji; Ueno, Yoshiyuki; Sakisaka, Shotaro; Kikuchi, Kentaro; Ebinuma, Hirotoshi; Yamashiki, Noriyo; Tamura, Sumito; Sugawara, Yasuhiko; Mori, Akira; Yagi, Shintaro; Shirabe, Ken; Taketomi, Akinobu; Arai, Kuniaki; Monoe, Kyoko; Ichikawa, Tatsuki; Taniai, Makiko; Miyake, Yasuhiro; Kumagi, Teru; Abe, Masanori; Yoshizawa, Kaname; Joshita, Satoru; Shimoda, Shinji; Honda, Koichi; Takahashi, Hiroki; Hirano, Katsuji; Takeyama, Yasuaki; Harada, Kenichi; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Fukushima, Nobuyoshi; Ota, Hajime; Komatsu, Tatsuji; Saoshiro, Takeo; Ishida, Jinya; Kouno, Hirotsugu; Kouno, Hirotaka; Yagura, Michiyasu; Kobayashi, Masakazu; Muro, Toyokichi; Masaki, Naohiko; Hirata, Keiichi; Watanabe, Yukio; Nakamura, Yoko; Shimada, Masaaki; Hirashima, Noboru; Komeda, Toshiki; Sugi, Kazuhiro; Koga, Michiaki; Ario, Keisuke;Takesaki, Eiichi; Maehara, Yoshihiko; Uemoto, Shinji; Kokudo, Norihiro; Tsubouchi, Hirohito; Mizokami, Masashi; Nakanuma, Yasuni; Tokunaga, Katsushi; Ishibashi, Hiromi


Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers
Tissue Antigens,80(4):305-16 2012(Oct.)
Author: Shiina T, Suzuki S, Ozaki Y, Taira H, Kikkawa E, Shigenari A, Oka A, Umemura T, Joshita S, Takahashi O, Hayashi Y, Paumen M, Katsuyama Y, Mitsunaga S, Ota M, Kulski JK, Inoko H


Long-term outcome of Japanese patients with type 1 autoimmune hepatitis
HEPATOLOGY,56(2):668-676 2012(Aug.)
Author:Yoshizawa, Kaname; Matsumoto, Akihiro; Ichijo, Tetsuya; Umemura, Takeji; Joshita, Satoru; Komatsu, Michiharu; Tanaka, Naoki; Tanaka, Eiji; Ota, Masao; Katsuyama, Yoshihiko; Kiyosawa, Kendo; Abe, Masanori; Onji, Morikazu


B型肝炎 universal vaccination へ向けて
肝臓,53(2):117-130 2012(Feb. 25)
Author:四柳 宏,田中 靖人,齋藤 昭彦,梅村 武司,伊藤 清顕,柘植 雅貴,高橋 祥一,中西 裕之,吉田 香奈子,世古口 悟,高橋 秀明,林 和彦,田尻 仁,小松 陽樹,菅内 文中,田尻 和人,上田 佳秀,奥瀬 千晃,八橋 弘,溝上 雅史


Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
JOURNAL OF GASTROENTEROLOGY,47(9):1006-13 2012
Author:Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S


Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.
HEPATOLOGY,56:668-76 2012
Author:Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M.


HLA class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
HEPATOLOGY,55:506-511 2012
Author:Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M; The Shinshu PBC Study Group.


Clinical characteristics of young-onset ischemic colitis
Dig Dis Sci,57:1652-9 2012
Author:Kimura T, Shinji A, Horiuchi A, Tanaka N, Nagaya T, Shigeno T, Nakamura N, Komatsu M, Umemura T, Arakura N, Matsumoto A, Tanaka E.


Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection.
Hum Immunol,73(3):298-300 2012
Author:Joshita S, Umemura T, Katsuyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Kamijo N, Ota M, Tanaka E.


Occult HBV感染とその対応 (新時代のウイルス性肝炎学--基礎・臨床研究の進歩) -- (特殊な病態におけるB型肝炎に対する対応)
日本臨床,69:515-519 2011(May)
Author:梅村 武司


B型肝炎の発症機序と病態 (新時代のウイルス性肝炎学--基礎・臨床研究の進歩) -- (B型肝炎の病態)
日本臨床,69:417-421 2011(May)
Author:田中 榮司,松本 晶博,梅村 武司


Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Hepatol Res,41(4):350-7 2011(Apr.)
Author:Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E


Genetic background of autoimmune hepatitis in Japan
JOURNAL OF GASTROENTEROLOGY,46(1):42-47 2011(Jan.)
Author:Yoshizawa, Kaname; Umemura, Takeji; Ota, Masao


Serum IL-10 and IL-12p40 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Antiviral Therapy,16(7):1073-8 2011
Author:Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E.


Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Hepatol Res,41:584-93 2011
Author:Yoneda S, Umemura T, Joshita S, Ichijo T, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E.


Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population.
Dis Markers,31:223-9 2011
Author:Ota M, Ito T, Umemura T, Katsuyama Y, Yoshizawa K, Hamano H, Kawa S. 


Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy.
Hepatol Res,41(9):904-9 2011
Author:Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka, E.


Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
JOURNAL OF GASTROENTEROLOGY,46(S1):48-55 2011
Author:Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E.


Association of serum cytokine levels with treatment response to pegylated interferon and ribavirin therapy in genotype 1 chronic hepatitis C patients.
The Journal of Infectious Diseases,203:1087-95 2011
Author:Yoneda S, Umemura T, Katsuyama Y, Kamijo A, Joshita S, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E.


A case of pyogenic liver abscess infected with Fusobacterium necrophorum depicted by microscopy and confirmed by tissue culture
Intern Med,50(17):1815-9 2011
Author:Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E.


免疫抑制・化学療法中に発生するde novo B型肝炎 (特集 B型肝炎ウイルス再活性化の問題点と対策)
消化器内科,51(4):386-390 2010(Oct.)
Author:梅村 武司


Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
JOURNAL OF CLINICAL GASTROENTEROLOGY,44(6):440-447 2010(Jun.)
Author:Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji


A Novel Heterophilic Antibody Interaction Involves IgG4
SCANDINAVIAN JOURNAL OF IMMUNOLOGY,71(2):109-114 2010(Feb.)
Author:Ito, T.; Kitahara, K.; Umemura, T.; Ota, M.; Shimozuru, Y.; Kawa, S.; Bahram, S.


Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
JOURNAL OF GASTROENTEROLOGY,45(6):666-672 2010(Jan.)
Author:Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi;Tanaka, Eiji


DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH
JOURNAL OF HEPATOLOGY,52(0):S373-S374 2010
Author:Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.


CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILUREDUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
JOURNAL OF HEPATOLOGY,52:S286-S286 2010
Author:Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res


Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
JOURNAL OF HEPATOLOGY,53(3):537-541 2010
Author:Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Nakamura M, Ishibashi H, Ota M, the Shinshu PBC Study Group.


Another cause of autoimmune hepatitis
HEPATOLOGY,52(1):389-340 2010
Author:Umemura T, Zen Y, Nakanuma Y, Kiyosawa K


A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
HUMAN IMMUNOLOGY,71(5):520-524 2010
Author:Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M, the Shinshu PBC Study Group


A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
INTERNAL MEDICINE,49(11):991-994 2010
Author:Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji


複数回治療後の再発性肝細胞癌の局所療法にソナゾイド^造影超音波が有用であった1例
肝臓,50(6):250-256 2009(May 25)
Author:米田 傑,城下 智,一條 哲也,上條 敦,小松 通治,梅村 武司,松本 晶博,吉澤 要,田中 榮司


A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid
HEPATOLOGY RESEARCH,39(2):207-212 2009(Feb.)
Author:Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji


免疫抑制・化学療法により発症するB型肝炎対策 : 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班劇症肝炎分科会および「肝硬変を含めたウイルス性肝疾患の治療の標準化に関する研究」班合同報告
肝臓,50(1):38-42 2009(Jan. 25)
Author:坪内 博仁,熊田 博光,清澤 研道,持田 智,坂井田 功,田中 榮司,市田 隆文,溝上 雅史,鈴木 一幸,與芝 眞彰,森脇 久隆,日比 紀文,林 紀夫,國土 典宏,藤澤 知雄,石橋 大海,菅原 寧彦,八橋 弘,井戸 章雄,滝川 康裕,井上 和明,桶谷 真,宇都 浩文,中山 伸朗,内木 隆文,多田 慎一郎,木曽 真一,矢野 公士,遠藤 龍人,田中 靖人,梅村 武司,熊谷 公太郎


広範囲の肝実質の脱落により奇異な肝形態を呈し自己免疫性肝炎が疑われた1例
日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy,51(1):48-54 2009(Jan. 20)
Author:城下 智,一條 哲也,吉澤 要,福島 万奈,小松 通治,新井 薫,田中 直樹,梅村 武司,松本 晶博,田中 榮司


Epidemiology of hepatocellular carcinoma in Japan
JOURNAL OF GASTROENTEROLOGY,44:102-107 2009
Author:Umemura, T; Ichijo, T; Yoshizawa, K; Tanaka, E; Kiyosawa, K


Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis
HUMAN IMMUNOLOGY,70:742-746 2009
Author:Umemura T, Katsuyama Y, Hamano H, Kitahara K, Takayama M, Arakura N, Kawa S, Tanaka E, Ota M.


A Novel Immunoglobulin-Immunoglobulin Interaction in Autoimmunity
PLOS ONE,3(2):- 2008(Feb.)
Author:Kawa, Shigeyuki; Kitahara, Kei; Hamano, Hideaki; Ozaki, Yayoi; Arakura, Norikazu; Yoshizawa, Kaname; Umemura, Takeji; Ota, Masao; Mizoguchi,Sadaaki; Shimozuru, Yasunori; Bahram, Seiamak


Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
CLINICAL INFECTIOUS DISEASES,47(5):E52-E56 2008
Author:Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H


Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese
HEPATOLOGY RESEARCH,38:689-695 2008
Author:Umemura T, Ota M, Yoshizawa K, Katsuyama Y, Ichijo T, Tanaka E, Kiyosawa K


Association of Autoimmune Pancreatitis With Cytotoxic T-lymphocyte Antigen 4 Gene Polymorphisms in Japanese Patients
AMERICAN JOURNAL OF GASTROENTEROLOGY,103(3):588-594 2008
Author:Umemura, T; Ota, M; Hamano, H; Katsuyama, Y; Muraki, T; Arakura, N; Kawa, S; Kiyosawa, K


腹壁への浸潤が疑われ, 画像検査が診断の契機となった肝放線菌症の1例
肝臓 = ACTA HEPATOLOGICA JAPONICA,48(11):553-558 2007(Nov. 25)
Author:武藤 英知,一條 哲也,小林 倫子,田中 直樹,梅村 武司,小松 通治,松本 晶博,吉澤 要,田中 榮司,上田 和彦,角谷 眞澄,清澤 研道


Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
CLINICAL IMMUNOLOGY,122(3):338-342 2007
Author:Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K


Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
LIVER INTERNATIONAL,28(8):1104-1111 2007
Author:Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E


ImmunoglobulinG4-hepatopathy: Association of IgG4-bearing plasma cells in liver with autoimmune pancreatitis
HEPATOLOGY,46:463-471 2007
Author:Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K.


IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis
AMERICAN JOURNAL OF GASTROENTEROLOGY,102(3):691-692 2007
Author:Hamano, H; Umemura, T; Uehara, T; Kawa, S; Kiyosawa, K


IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis
GUT,56(10):1471-1472 2007
Author:Umemura, T; Zen, Y; Hamano, H; Ichijo, T; Kawa, S; Nakanuma, Y; Kiyosawa, K


Epidemiology of hepatocellular carcinoma in Japan
HEPATOLOGY RESEARCH,37(S2):S95-S100 2007
Author:Umemura, T; Kiyosawa, K


Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
JOURNAL OF VIRAL HEPATITIS,14(1):48-54 2007
Author:Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K


Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
LIVER INTERNATIONAL,26(8):956-963 2006
Author:Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K


Severe hepatic injury caused by orlistat
AMERICAN JOURNAL OF MEDICINE,119(8):E7-E7 2006
Author:Umemura, T; Ichijo, T; Matsumoto, A; Kiyosawa, K


Quantitative analysis of anti-hepatitis C virus anti body-secreting B cells in patients with chronic hepatitis C
HEPATOLOGY,43(1):91-99 2006
Author:Umemura, T; Wang, RYH; Schechterly, C; Shih, JWK; Kiyosawa, K; Alter, HJ


Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
JOURNAL OF MEDICAL VIROLOGY,78(1):68-73 2006
Author:Misawa, N; Matsumoto,A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura,T; Maki, N; Kimura, T; Kiyosawa, K


HepatitisB virus RNA is measurable in serum and canbe a new marker for monitoring lamivudine therapy
JOURNAL OF GASTROENTEROLOGY,41(8):785-790 2006
Author:Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K


Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients
GUT,55(9):1367-1368 2006
Author:Umemura, T; Ota, M; Hamano, H; Katsuyama, Y; Kiyosawa, K; Kawa, S


Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
EUROPEAN JOURNAL OF HAEMATOLOGY,77(3):255-258 2006
Author:Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K


A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
HEPATOLOGY,44(4):228A-228A 2006
Author:Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K


Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
JOURNAL OF VIRAL HEPATITIS,12(4):439-442 2005
Author:Tanaka, E;Matsumoto, A; Takeda, N; Li, TC; Umemura,T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K


Wilson 病の治療と発症予防
肝臓 = ACTA HEPATOLOGICA JAPONICA,45(9):459-462 2004(Sep. 25)
Author:梅村 武司,田中 榮司,清澤 研道


Hepatocellular carcinoma: Recent trends in Japan
GASTROENTEROLOGY,127(5):S17-S26 2004
Author:Kiyosawa, K; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Gad, A; Tanaka, E


Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
JOURNAL OF INFECTIOUS DISEASES,188(10):1545-1552 2003
Author:Umemura, T; Tanaka, E; Ostapowicz, G; Brown, KE; Heringlake, S; Tassopoulos, NC; Wang, RYH; Yeo, AET; Shih, JWK; Orii, K; Young, NS; Hatzakis, A; Manns, MP; Lee, WM; Kiyosawa, K; Alter, HJ


Clinical significance of SEN virus infection in patients on maintenance haemodialysis
NEPHROLOGY DIALYSIS TRANSPLANTATION,18(2):348-352 2003
Author:Kobayashi, N; Tanaka, E; Umemura, T; Matsumoto, A; Iijima, T; Higuchi, M; Hora, K; Kiyosawa, K


The role of SEN virus infection in various liver diseases from different geographical regions.
HEPATOLOGY,36(4):646A-646A 2002
Author:Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ


SEN virus: Response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
HEPATOLOGY,35(4):953-959 2002
Author:Umemura, T; Alter, HJ; Tanaka, E; Orii, K; Yeo, AET; Shih, JWK; Matsumoto, A; Yoshizawa, K; Kiyosawa, K


Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)
FEBS LETTERS,510(3):171-174 2002
Author:Umemura, T; Tanaka, Y; Kiyosawa, K; Alter, HJ; Shih, JWK


The evolutionary rate of SEN virus, a newlyidentified single-stranded circular DNA virus, is more similar to RNA viruses than classic DNA viruses.
HEPATOLOGY,34(4):636A-636A 2001
Author:Umemura, T; Tanaka, Y; Kiyosawa, K; Alter, HJ; Shih, JW


SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
HEPATOLOGY,34(4):487A-487A 2001
Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K


SEN virus infection and its relationship to transfusion-associated hepatitis
HEPATOLOGY,33:1303-1311 2001
Author:Umemura T, Yeo AET, Sottini A, Moratto A, Tanaka Y, Wang RYH, Shih JWK, Donahue P, Primi D, Alter HJ.


Association between SENvirus infection and hepatitis C in Japan
JOURNAL OF INFECTIOUS DISEASES,184(10):1246-1251 2001
Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K


The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
HEPATOLOGY,32(4):381A-381A 2000
Author:Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa,K; Primi, D


T cell repertoire in the liver of patients with primary biliary cirrhosis
HUMAN IMMUNOLOGY,61(7):675-683 2000
Author:Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo,T; Umemura, T; Tanaka, E; Kiyosawa,K


Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
CLINICAL AND EXPERIMENTAL IMMUNOLOGY,121(1):120-126 2000
Author:Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa, K


TT virus infection in an area of high-endemicity for hepatitis C
HEPATOLOGY RESEARCH,13(3):212-220 1999
Author:Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K


T cell repertoire in the liver of patients with autoimmune hepatitis
HUMAN IMMUNOLOGY,60(9):806-815 1999
Author:Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K


Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
HEPATOLOGY RESEARCH,14(2):161-170 1999
Author:Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K


C型肝炎多発地域におけるTTV感染の疫学的検討
日本臨床,57:1397-1401 1999
Author:梅村武司


胆嚢原発と考えられた悪性線維性組織球腫の1例 : 本邦報告例の検討
日本消化器病學會雜誌 = The Japanese journal of gastro-enterology,95(2):161-166 1998(Feb. 05)
Author:折井 幸司,梅村 武司,松沢 正浩,吉江 崇宏,田村 泰夫,山村 伸吉,飯島 義浩,長田 敦夫,代田 廣志,中村 智次


TT virus infection in high- and non-endemicity areas for hepatitis C.
HEPATOLOGY,28(4):365A-365A 1998
Author:Umemura, T; Tanaha, E; Orii, K; Imai, H; Yoshizawa, K; Ota, M; Kiyosawa, K


Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
HEPATOLOGY,28(4):279A-279A 1998
Author:Tanaka, E; Aoyagi, K; Nishizawa, Y; Umemura, T;Orii, K; Rokuhara, A; Iijima, A; Imai, H; Yoshizawa, K; Yagi, S; Hasegawa, A; Kiyosawa, K


脾動脈塞栓術後脾摘を施行したHairy cell leukemiaの1例
信州医学雑誌,45(1):27-34 1997(Feb. 10)
Author:梅村 武司,森下 博史,松沢 正浩,折井 幸司,高山 伸,吉江 崇宏,田村 泰夫,飯島 義浩,長田 敦夫,大畑 武夫,門馬 正志,中村 智次,林 正孝


十二指腸水平部憩室からの出血に純エタノール局注療法が有効であった1例
Endosc Forum digest dis,11:237-241 1995
Author:梅村武司


Presentations
C型肝炎に対するDAA治療によるウイルス学的著効が肝機能と肝線維化改善に与える臨床的影響
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、梅村武司


実臨床における核酸アナログ等未介入例・核酸アナログ治療例・ドラックフリー例のB型肝炎の臨床的特徴と実態
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:城下智、松本晶博、梅村武司


M2BPGiおよびAutotaxinは薬物性肝障害における組織学的炎症を反映し得るか
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:山崎智生、城下智、梅村武司


原発性胆汁性胆管炎(PBC)における初診時生化学的検査所見と予後予測式が予測する予後との関連
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:山下裕騎、城下智、梅村武司


原発性胆汁性胆管炎の急激な病状悪化の原因がE型肝炎ウイルスの急性感染であった1剖検例
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:小山みずき、山崎智生、山下裕騎、杉浦亜弓、藤森尚之、城下智、 梅村武司、岡本宏明


進行肝細胞癌に対する分子標的薬治 療患者の臨床的特徴とシーケンシヤル療法の有用性
第56回 日本肝癌研究会 2020(Dec. 22)
Presenter:城下智, 山下裕騎, 杉浦亜弓, 山崎智生, 梅村武司


C型肝炎に対するDAA治療によるウイルス学的著効が肝機能と肝線維化改善に与える臨床的影響
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:杉浦亜弓, 城下智, 梅村武司


直接作用型抗ウイルス剤によるHCV排除が脂質代謝系および脂質プロファイルの量的変動と質的変動に与える影響
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:城下智, 山下裕騎, 梅村武司


内科治療抵抗性のシャント型肝性脳症に対してB-RTOを施行した3症例の検討
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:若林俊一, 山崎智生, 小林浩幸, 山下裕騎, 杉浦亜弓, 城下智, 梅村武司


予後・病型・成因ごとにみた急性肝不全におけるM2BPGiの臨床的意義の検討
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:山崎智生, 城下智, 梅村武司


肝原発MALT(Mucosa-Associated Lymphoid Tissue)リンパ腫を合併したB型肝炎無症候性キャリアの1例
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:山下裕騎, 城下智, 梅村武司


PBC(Primary biliary cholangitis)患者の骨密度低下拾い上げにおける骨粗鬆症関連マーカーの臨床的有用性について
第43回日本肝臓学会東部会 2020(Dec. 04)
Presenter:山下裕騎, 城下智, 梅村武司


胆嚢管の壁肥厚初見に対して、どのようにアプローチすべきか?
日本消化器病学会第67回甲信越支部例会日本消化器内視鏡学会第90回甲信越支部例会 2020(Nov. 21)
Presenter:加古里子、田中友之、芦原典宏、倉石康弘、渡邉貴之、梅村武司


肝類洞閉塞症候群様の病態で発症した肝アミロイドーシスの一剖検例
第67回日本消化器病学会甲信越支部例会 2020(Nov. 21)
Presenter:土屋智章、杉浦亜弓、山下裕騎、山崎智生、城下智、梅村武司


超音波内視鏡で膵管壁肥厚様所見を認めた自己免疫性膵炎の1例
第67回日本消化器病学会甲信越支部例会 2020(Nov. 21)
Presenter:清水祐樹、田中友之、加古里子、芦原典宏、倉石康弘、渡邉貴之、梅村武司


⾃⼰免疫性膵炎とIgG4関連硬化性胆管炎に合併する縦隔・肺⾨リンパ節腫⼤の臨床的意義に関する検討
JDDW2020 2020(Nov. 05)
Presenter:倉石康弘, 渡邉貴之, 梅村武司


C型肝炎に対するDAA治療後M2BPGi低値群のSVR後肝発癌症例の臨床的特徴
JDDW2020 2020(Nov. 05)
Presenter:杉浦亜弓, 城下智, 山下裕騎, 山崎智生, 梅村武司


DAA治療によるHCV排除はHDL-Cの量的変動のみならず,質的な変動にも関与する
JDDW2020 2020(Nov. 05)
Presenter:城下智, 杉浦亜弓, 梅村武司


PBCにおける脂質異常症とLOX-1との関連
JDDW2020 2020(Nov. 05)
Presenter:山下裕騎, 城下智, 梅村武司


内視鏡的胆汁逆流所見はバレット食道の独立した関連因子である
JDDW2020 2020(Nov. 05)
Presenter:岩谷勇吾, 長屋匡信, 梅村武司


ペマフィブラートが奏功した,小児期発症AIHの加療中にPBCと高TG血症を合併した1例
第147回日本内科学会信越地方会 2020(Oct. 04)
Presenter:高裕信、山下裕騎、山崎智生、小林浩幸、若林俊一、杉浦亜弓、城下智、梅村武司


自己免疫性肝炎の病態に関連するkiller cell immunoglobulin-like receptors(KIR)/HLAの役割についての検討
第106回日本消化器病学会総会 2020(Aug. 11)
Presenter:梅村武司、城下智、齋藤博美


ALT正常C型慢性肝炎患者に対して全例「ウイルス排除」に向けた直接作用型抗ウイルス剤治療の臨床的意義
第106回日本消化器病学会総会 2020(Aug. 11)
Presenter:城下智、杉浦亜弓、梅村武司


非慢性膵炎例における膵外分泌機能の検討
第106回日本消化器病学会総会 2020(Aug. 11)
Presenter:;芦原典宏、金井圭太、渡邉貴之、加古里子、倉石康弘、小澤真希子、梅村武司


原発性胆汁性胆管炎の非侵襲的病期診断法の臨床的有用性
第117 回日本内科学会総会・講演会 2020(Aug. 07)
Presenter:城下智、山下裕騎、杉浦亜弓、山崎智生、梅村武司


C型肝炎に対するDAA治療における経時的なM2BPGi測定の臨床的意義とSVR後肝発癌との関連
JDDW2019 2019(Nov. 21)
Presenter:杉浦亜弓、城下智、梅村武司、高橋芳之、栗林直矢、山崎智生、藤森尚之、松本晶博、田中榮司


薬物性肝障害における肝病理学的検討の意義
JDDW2019 2019(Nov. 21)
Presenter:山崎智生, 城下智1, 梅村武司


嚢胞性肝転移を呈し腎細胞癌術後9年目に肝切除を施行した一例
第65回日本消化器病学会甲信越支部例会 2019(Nov. 02)
Presenter:清水祐樹、杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、梅村武司、上原剛、清水明、副島雄二


C型慢性肝炎のDAA治療におけるVCTE™の臨床的特徴の検討
日本超音波医学会第31 回関東甲信越地方会学術集会 2019(Oct. 19)
Presenter:杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、松本晶博、梅村武司


内科治療抵抗性の門脈大循環シャント関連肝性脳症に対しB-RTO が著効した1 例
第145回日本内科学会信越地方会 2019(Oct. 12)
Presenter:畔上周子、山崎智生、山下裕騎、杉浦亜弓、藤森尚之、城下智、梅村武司、深松史聡、黒住昌弘、藤永康成


発作性心房細動に対するカテーテルアブレーション後に生じた消化管蠕動障害の1例
第145回日本内科学会信越地方会 2019(Oct. 12)
Presenter:小林克己、芦原典宏、加古里子、倉石康弘、小澤真希子、金井圭太、渡邉貴之、梅村武司、吉江幸司


炎症性腸疾患の病型に関わるKIR-HLAペアリング効果
第28回日本組織適合性学会大会 2019(Sep. 21)
Presenter:鈴木宏、城下智、杉浦亜弓、齋藤博美、平山敦大、赤羽由紀、山崎麻美、勝山善彦、梅村武司、太田正穂


KIR/HLAは自己免疫性肝炎の疾患感受性、病態進展と関連する
第28回日本組織適合性学会大会 2019(Sep. 21)
Presenter:梅村武司、城下智、赤羽由紀、山崎麻美、勝山善彦、太田正穂


血小板増多を呈する脾腫を契機に骨髄増殖性腫瘍の診断に至った1症例
第26回日本門脈圧亢進症学会総会 2019(Sep. 12)
Presenter:城下智、仁科さやか、山下裕騎、梅村武司


腎機能障害と肝硬変患者の予後の関連性についての後方視的解析
第26回日本門脈圧亢進症学会総会 2019(Sep. 12)
Presenter:山下裕騎、梅村武司、城下智、髙橋芳之、杉浦亜弓、山崎智生、藤森尚之、松本晶博


長野県におけるC型慢性肝炎に対する直接作用型抗ウイルス剤治療の実臨床における成績と課題
第70回長野県医学会 2019(Jul. 28)
Presenter:杉浦亜弓、城下智、山下裕騎、髙橋芳之、山崎智生、藤森尚之、松本晶博、梅村武司


直接作用型抗ウイルス剤治療によるC型肝炎ウイルス排除が脂質変動と脂質判定区分の変化に与える影響
第60 回日本人間ドック学会学術大会 2019(Jul. 25)
Presenter:城下智、梅村武司、田中榮司


PersistentlyNormalALTC型慢性肝炎がDAA治療後の肝発癌に与える影響
第55回日本肝癌研究会 2019(Jul. 04)
Presenter:城下智、杉浦亜弓、梅村武司


興味深い画像所見を呈した通常型膵癌の1例
第86回 日本消化器内視鏡学会甲信越支部例会 2019(Jun. 09)
Presenter:平林正裕、小澤真希子、加古里子、芦原典宏、倉石康弘、金井圭太、渡邉貴之、梅村武司


赤痢アメーバ特異的PCR法が陽性であったアメ ーバ性肝膿瘍の 1例
第64回 日本消化器病学会甲信越支部例会 2019(Jun. 08)
Presenter:小山みずき、杉浦亜弓、城下智、高橋芳之、栗林直矢、山崎智生、藤森尚之、堀内一樹、松本剛、梅村武司


当院における急性肝不全,慢性肝不全,Acute-On-Chronic-Liver Failure症例の予後因子に関する検討
第55回日本肝臓学会総会 2019(May 30)
Presenter:髙橋芳之、城下智、梅村武司


クローン病の寛解期にサイトメガロウィルス肝炎を発症した1例
第55回日本肝臓学会総会 2019(May 30)
Presenter:南澤昌郁、山崎智生、城下智、高橋芳之、栗林直矢、杉浦亜弓、藤森尚之、梅村武司、松本晶博、田中榮司


C型慢性肝炎におけるDAAs難治例の臨床的特徴についての検討
第55回日本肝臓学会総会 2019(May 30)
Presenter:杉浦亜弓、城下智、梅村武司


Persistently Normal ALT C 型慢性肝炎における Direct Acting Antivirals 療法の臨床的特徴と実態
第55回日本肝臓学会総会 2019(May 30)
Presenter:城下智、杉浦亜弓、梅村武司


原発性胆汁性胆管炎の肝硬変進展に関する予後予測式の有効性
第55回日本肝臓学会総会 2019(May 30)
Presenter:城下智、山下裕騎、梅村武司


当科におけるHBV再活性化および核酸アナログ予防内服の検討
第55回日本肝臓学会総会 2019(May 30)
Presenter:山崎智生、城下智、梅村武司


実臨床におけるグレカプレビル/ピブレンタスビル治療の有用性と再治療例の臨床的特徴
第105回日本消化器病学会総会 2019(May 09)
Presenter:杉浦亜弓、城下智、梅村武司、髙橋芳之、栗林直矢、山崎智生、藤森尚之、松本晶博、田中榮司


C型慢性肝炎におけるDAA治療failureの予測因子の検討
第105回日本消化器病学会総会 2019(May 09)
Presenter:梅村武司、山崎智生、城下智


慢性肝疾患におけるATX およびM2BPGi の非侵襲的病期診断マーカーとしての有用性とその臨床的意義
第105回日本消化器病学会総会 2019(May 09)
Presenter:城下智、梅村武司、田中榮司


C型肝炎におけるPNALT症例の特徴とDAAs治療の意義
第116回日本内科学会総会・講演会  2019(Apr. 26)
Presenter:城下智、杉浦亜弓、梅村武司、田中榮司